Other News To Note
• Retrosense Therapeutics LLC, of Ann Arbor, Mich., received a grant of $250,000 from the Foundation Fighting Blindness to support development of its investigational gene therapy product based on genes from blue-green algae. The foundation may invest additional funds upon achievement of certain milestones in the research. The company anticipates beginning clinical trials in two to four years.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter